Spots Global Cancer Trial Database for A Trial of ZL-1201 in Subjects With Advanced Cancer
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: A Trial of ZL-1201 in Subjects With Advanced Cancer
Official Title: First in Human, Phase I Trial of ZL-1201 in Subjects With Advanced Cancer
Study ID: NCT04257617
Conditions
Interventions
Study Description
Brief Summary: First in Human, Phase I Trial of ZL-1201 in Subjects with Advanced Cancer
Detailed Description: This is a first-in-human, dose escalation trial of ZL-1201. The major aims of the study are to define the safety profile of this new drug, and to determine a recommended dose and schedule for potential additional trials.
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
US2004, Phoenix, Arizona, United States
US2005, Jacksonville, Florida, United States
US2001, Rochester, Minnesota, United States
US2003, Saint Louis, Missouri, United States
US2002, New York, New York, United States
CN1003, Chongqing, Chongqing, China
CN1002, Hangzhou, Zhejiang, China
Contact Details
Name: Study Physician
Affiliation: Zai Laboratory
Role: STUDY_DIRECTOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
